Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Actinogen Medical ( (AU:ACW) ) is now available.
Actinogen Medical Limited has announced a proposed placement of up to 269,833,333 ordinary fully paid shares, with an expected issue date of 9 February 2026. The capital raising, conducted via a placement structure, is intended to expand the company’s securities on issue and may strengthen its balance sheet and funding capacity, with potential implications for existing shareholders through increased dilution and for the company’s ability to pursue its development and commercial objectives.
The most recent analyst rating on (AU:ACW) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited (ASX: ACW) is an Australia-listed biotechnology company focused on developing medical therapies, with its shares traded as ordinary fully paid securities on the ASX.
YTD Price Performance: -26.23%
Average Trading Volume: 5,840,451
Technical Sentiment Signal: Hold
Current Market Cap: A$143.6M
Learn more about ACW stock on TipRanks’ Stock Analysis page.